- Corporate Officers - K
- Kurtz Ronald M Md
Insider Trading History of Kurtz Ronald M Md
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kurtz Ronald M Md since 2005.
This trader's CIK number is 1295469.
At the time of last reporting, Kurtz Ronald M Md was the President & CEO of Rxsight, Inc.. (stock ticker symbol RXST).
Also see all insider trading activities at Rxsight, Inc..
Note that in the past
Kurtz Ronald M MD also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Rxsight, Inc. (RXST) by Kurtz Ronald M Md
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | RXST | 0 | $0 | 40,000 | $2,405,880 | 23,450 | $300,221 |
| 2023 | RXST | 0 | $0 | 62,500 | $2,512,702 | 0 | $0 |
| 2021 | RXST | 128,638 | $2,050,379 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Intralase Corp (ILSE) by Kurtz Ronald M Md
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | ILSE | 0 | $0 | 110,000 | $2,164,406 | 0 | $0 |
Insider trading activities at 2 companies by Kurtz Ronald M Md:
1. Rxsight, Inc. (RXST)
2. Intralase Corp (ILSE)
Table 1. Insider trading of Rxsight, Inc. (RXST) by Kurtz Ronald M Md
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-09 | RXST | Option Ex | 9,950 | 9.71 | 96,614 |
| 2024-07-11 | RXST | Option Ex | 13,500 | 15.08 | 203,607 |
| 2024-05-03 | RXST | Sale | 40,000 | 60.15 | 2,405,880 |
| 2023-12-27 | RXST | Sale | 22,500 | 41.09 | 924,502 |
| 2023-12-14 | RXST | Sale | 40,000 | 39.70 | 1,588,200 |
| 2021-08-03 | RXST | Buy | 125,000 | 16.00 | 2,000,000 |
| 2021-08-05 | RXST | Buy | 3,638 | 13.85 | 50,379 |
Table 2. Insider trading of Intralase Corp (ILSE) by Kurtz Ronald M Md
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-08-08 | ILSE | Sale | 2,000 | 19.48 | 38,960 |
| 2005-08-01 | ILSE | Sale | 15,000 | 20.80 | 312,000 |
| 2005-07-27 | ILSE | Sale | 6,000 | 21.99 | 131,940 |
| 2005-07-26 | ILSE | Sale | 12,000 | 19.03 | 228,324 |
| 2005-07-18 | ILSE | Sale | 9,000 | 18.10 | 162,900 |
| 2005-07-14 | ILSE | Sale | 3,000 | 20.88 | 62,640 |
| 2005-07-11 | ILSE | Sale | 12,000 | 19.89 | 238,680 |
| 2005-07-05 | ILSE | Sale | 12,000 | 19.87 | 238,392 |
| 2005-06-27 | ILSE | Sale | 12,000 | 19.64 | 235,680 |
| 2005-06-20 | ILSE | Sale | 9,000 | 19.15 | 172,350 |
| 2005-06-14 | ILSE | Sale | 18,000 | 19.03 | 342,540 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kurtz Ronald M Md
(President & CEO of Rxsight, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.